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Spatially clustered loci with multiple enhancers are
frequent targets of HIV-1 integration
Bojana Lucic1,11, Heng-Chang Chen 2,3,11, Maja Kuzman 4,11, Eduard Zorita 2,3,11, Julia Wegner1,10,
Vera Minneker5, Wei Wang6, Raffaele Fronza6, Stefanie Laufs6, Manfred Schmidt6, Ralph Stadhouders7,8,
Vassilis Roukos 5, Kristian Vlahovicek 4, Guillaume J. Filion 2,3,9 & Marina Lusic 1
HIV-1 recurrently targets active genes and integrates in the proximity of the nuclear pore
compartment in CD4+ T cells. However, the genomic features of these genes and the
relevance of their transcriptional activity for HIV-1 integration have so far remained unclear.
Here we show that recurrently targeted genes are proximal to super-enhancer genomic
elements and that they cluster in speciﬁc spatial compartments of the T cell nucleus. We
further show that these gene clusters acquire their location during the activation of T cells.
The clustering of these genes along with their transcriptional activity are the major deter-
minants of HIV-1 integration in T cells. Our results provide evidence of the relevance of the
spatial compartmentalization of the genome for HIV-1 integration, thus further strengthening
the role of nuclear architecture in viral infection.
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Integration of the proviral genome into the host chromosomalDNA is one of the deﬁning features of retroviral replication1–3.Following integration, the viral genome can either be expres-
sed or enter a transcriptionally dormant stage, establishing a
reservoir of latently infected cells. Latently infected cells are
indistinguishable from the non-infected ones and are therefore
not eliminated by immune clearance mechanisms or recognized
by current antiretroviral treatments4,5. Resting CD4+ T cells of
the memory phenotype represent the main reservoir of latent
human immunodeﬁciency virus type 1 (HIV-1)6. However, it is
still unclear how these reservoirs are established, as HIV-1 does
not efﬁciently infect resting T cells due to different blocks at both
pre-integration and integration levels4,7–10. One possible expla-
nation is that some of the activated CD4+ T cells revert back to
the resting state upon infection with HIV-1, generating the
reservoirs of silenced but replication-competent viruses4. What
remains still to be deﬁned is how this transition from activated to
resting state occurs, and what changes in the cellular genome and
chromatin are involved11,12.
In activated CD4+ T cells, the viral DNA enters the nucleus to
access chromatin13 passing through the nuclear pore complex
(NPC)14–16. Nuclear pore proteins are important factors for
the viral nuclear entry17, as well as for the positioning and
consequent integration of the viral DNA into the cellular
genome3,13–16,18,19. Integration is not a random process, as HIV-
1 predominantly integrates into active genes in gene-dense
regions20, mediated by the action of viral proteins integrase (IN)
and capsid (CA). Through its interaction with LEDGF/p7521–23,
IN guides the integration into gene bodies. This pattern is shifted
toward 5′ end regions of genes22,24,25 or toward gene-poor
regions25 when LEDGF/p75 is depleted. Through its interaction
with cleavage and polyadenylation speciﬁcity factor 6 (CPSF6),
HIV-1 CA also contributes to the location of the viral
genome24,26,27. Lack of CPSF6 arrests the incoming viral particles
at the level of the NPC27 or retargets the integrating viral DNA to
the lamina-associated heterochromatin domains26.
It is well established that HIV-1 targets open chromatin regions
of active transcription and regions bearing enhancer
marks20,28,29. Unlike typical enhancers, genomic elements known
as super-enhancers (SEs) are deﬁned by high levels of acetylated
lysine 27 of histone 3 (H3K27ac) and binding of transcriptional
co-activators, such as bromodomain-containing protein 4
(BRD4), the mediator complex30, and the p300 histone acetyl-
transferase30–32. SEs control the expression of genes that deﬁne
cell identity30,32–34, and in case of CD4+ T cells, relevant for
HIV-1 infection, they control cytokines, cytokine receptors, and
transcription factors regulating T cell-speciﬁc transcriptional
programs35. Strikingly, one of the strongest immune-activation
SEs36,37 encoding for transcription factor BACH2 is among the
most frequently targeted HIV-1 integration genes38,39. SE ele-
ments of cell identity genes were shown to be bound by nuclear
pore proteins, which regulate their expression40,41 and anchor
them to the nuclear periphery41. Moreover, SEs seem to play a
general role in organizing the genome through higher-order
chromatin structures and architectural chromatin loops42–44.
Evidence accumulated in the past decade has revealed that
the chromosomal contacts, achieved by genome folding and
looping, deﬁne separate compartments in the nucleus45. Hi-C
data have shown that transcribed genes make preferential
contacts with other transcribed genes, forming a spatial cluster
known as the A compartment46,47. Reciprocally, silent genes
and intergenic regions form a spatial cluster known as the B
compartment. The loci of the B compartment are usually in
contact with the nuclear lamina48, i.e., at the periphery of the
nucleus, where low levels of gene expression and hetero-
chromatin histone signatures are found. In fact, these regions
are almost completely avoided by HIV-118,25,26, whereas HIV-1
targets regions of open chromatin, which in some studies map
in proximity to the NPC18,19,49.
This suggests that a complex and dynamic interplay between
the incoming virus, the host cell chromatin, and the dynamic
nuclear organization contribute to the selection of genomic
sequences into which HIV-1 integrates.
Here we ﬁnd that HIV-1 integrates in proximity of SEs in
patients and in T cell cultures in vitro. The observed phenomenon
does not depend on the activity of SEs but on their position in
spatial neighborhoods where HIV-1 insertion is facilitated.
Consistently, HIV-1 integration hotspots cluster in the nuclear
space and tend to contact SEs. Finally, we ﬁnd that SE activity is
critical to reorganize the genome of activated T cells, showing that
they indirectly contribute to HIV-1 insertion biases.
Results
HIV-1 integrates in genes proximal to SEs. We assembled a list
of 4031 HIV-1 integration sites from activated primary CD4+
T cells infected in vitro (ref. 50 and this study) and 9519 insertion
sites from 6 studies from HIV-1 patients38,39,51–54 (Supplemen-
tary Table 1). Ten thousand seven hundred and thirty-ﬁve inte-
grations were in gene bodies (77% averaged over patient studies
and 84% over in vitro infection studies), targeting a total of 5601
different genes (Supplementary Fig. 1a). This insertion dataset is
not saturating (Supplementary Fig. 1b), yet we found that a subset
of genes are recurrent HIV-1 targets, consistent with our previous
ﬁndings18. We thus deﬁned recurrent integration genes (RIGs) as
genes with ≥1 HIV-1 integrations in at least 2 out of 8 datasets
(see “Methods”), yielding a total of 1648 RIGs (Supplementary
Fig. 1c).
To characterize RIGs, we extracted protein-coding genes
without HIV-1 insertions in any dataset (called non-RIGs in
the analysis, consisting of 13,140 genes) and compared their
chromatin immunoprecipitation sequencing (ChIP-Seq) features
in primary CD4+ T cells. We ﬁrst analyzed the levels of
epigenomic features on protein-coding genes (Fig. 1a). As
previously reported18,50, we observed higher levels of H3K27ac,
H3K4me1, and H3K4me3, as well as BRD4 and mediator of RNA
polymerase II transcription subunit 1 (MED1) at transcription
start sites of RIGs vs non-RIGs. Histone proﬁles of H3K36me3
and H4K20me1 were higher throughout RIG gene bodies, while
the repressive transcription mark H3K27me3 was lower on RIGs
vs non-RIGs. Of note, the mark of facultative heterochromatin
H3K9me2 was depleted at transcription start sites of RIGs but
remained unchanged throughout the gene body of RIGs vs non-
RIGs.
In order to test the speciﬁcity of chromatin signatures of HIV-1
integration sites, we adapted the receiver operating characteristic
(ROC) analysis55,56. We used control sites matched according to
the distance to the nearest gene (see “Methods”) and conﬁrmed
signiﬁcant enrichment of the following genomic features:
H3K27ac, H3K4me1, BRD4, MED1, H3K36me3, and
H4K20me1 (Fig. 1b). The marks H3K27ac, H3K4me1, and
H3K36me3, characteristic of active enhancers57, cell type-speciﬁc
enhancers58, and bodies of transcribed genes59, respectively, were
the most enriched in the proximity of insertion sites. Consistent
with the presence of H3K27ac and H3K4me1, we also found
signiﬁcant enrichment of BRD4, a constituent of SE genomic
elements30,32 (Fig. 1b). On average, 60% of insertion sites were
signiﬁcantly enriched in these chromatin marks (not shown)
while we observed depletion of H3K27me3 and H3K9me2 in the
proximity of insertion sites. Interestingly, we did not observe a
statistically signiﬁcant enrichment of H3K4me3 in the proximity
of insertion sites.
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To conﬁrm these trends, we identiﬁed SEs in activated CD4+
T cells using H3K27ac ChIP-Seq and merged them with the SEs
in activated CD4+ T cells from dbSuper60,61. We obtained 2584
SEs, intersecting 564 RIGs (34.22%, Supplementary Fig. 1d). In
addition, the more a RIG is targeted by HIV-1 (i.e., the higher
the number of datasets where HIV-1 insertions are found in the
gene), the closer it lies to SEs on average (Fig. 1c). In contrast,
the insertion sites of the retrovirus HTLV-162 (human T
lymphotropic virus type 1) were not enriched in SE marks
(Supplementary Fig. 1e), while murine leukemia virus (MLV)
showed a strong enrichment in all SE marks as expected63.
Figure 1d shows the integration biases at gene scale on FOXP1,
STAT5B, and BACH2, three highly targeted RIGs involved in T
cell differentiation and activity. The ChIP-Seq proﬁles of
H3K27ac, H3K36me3, and BRD4 indicate prominent clustering
of HIV-1 insertion sites near the SEs deﬁned by those marks.
Thus HIV-1 displays speciﬁc preference to integrate into genes
proximal to SEs, herein deﬁned as genomic elements of
retroviral integrations.
RIGs are proximal to SEs regardless of their expression. HIV-1
is known to integrate into highly expressed genes20,29. It is thus
possible that genes with an SE are targeted more often because
they are expressed at a higher level. To test whether this is the
case, we measured the transcript abundance of protein-coding
genes in CD3/CD28-activated CD4+ T cells by RNA sequencing
(RNA-Seq). The mean expression of genes with HIV-1 insertions
is higher than those not targeted by HIV-1 (Fig. 2a). More spe-
ciﬁcally, 21.4% of protein-coding genes targeted by HIV-1 are in
the top 10% most expressed genes, compared to 6.07% of non-
targeted genes. Moreover, the genes more often targeted by HIV-
1 (RIGs) are expressed at higher levels (Fig. 2b), thus conﬁrming
that HIV-1 is biased toward highly expressed genes.
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Fig. 1 HIV-1 integration hotspots are within genes proximal to super-enhancers (SEs). a Metagene plots of H3K27ac, H3K4me1, H3K4me3, BRD4, MED1,
H3K36me3, H4K20me1, H3K9me2, and H3K27me3 ChIP-Seq signals in recurrent integration genes (RIGs), which are protein coding in red and the rest of
the protein-coding genes that are not targeted by HIV-1 (no RIGs) in black. b ROC analysis represented in heatmap summarizing the co-occurrence of
integration sites and epigenetic modiﬁcation obtained by ChIP-Seq for H3K27ac, H3K4me1, BRD4, MED1, H3K36me3, H4K20me1, H3K4me3, H3K27me3,
and H3K9me2. HIV-1 integration datasets are shown in the columns, and epigenetic modiﬁcations are shown in rows. Associations are quantiﬁed using the
ROC area method; values of ROC areas are shown in the color key at the right. c Distance to the nearest SE in activated CD4+ T cells. Box plots represent
distances from the gene to the nearest SE grouped by number of times the gene is found in different datasets. d FOXP1, STAT5B, and BACH2 IS (black)
superimposition on H3K27ac (orange), SE (blue), H3K36me3 (green), and BRD4 (violet) ChIP-Seq tracks
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On average, genes with a SE are expressed at higher levels than
those without (Fig. 2c). This trend is more subtle for RIGs, as they
are expressed at a high level, with or without SEs (Fig. 2c,
compare the blue boxes). However, RIGs are more often in the
proximity of SEs than non-RIGs, irrespective of their expression
(Fig. 2d). In particular, 19.05% of RIGs that are silent also have a
proximal SE, while this is true for only 1.5% of the silent genes
that were never found to be HIV-1 targets (Fig. 2d, leftmost
panel). The trend remains the same for expressed genes (Fig. 2d)
after dividing them into “low,” “medium,” and “high” expression
groups (see “Methods”). In summary, our gene expression
analysis suggests that genes recurrently targeted by HIV-1 have
adjacent SE elements, irrespective of their transcriptional levels.
We next assessed the relationship between HIV-1 integration
and transcription of genes controlled by SEs by using JQ1, a
bromodomain and extraterminal domain protein inhibitor that
prevents BRD4 binding to acetylated chromatin64 and causes a
subsequent dysregulation of RNA Pol II binding31.
MYC is known to be regulated by SEs31, so we used the MYC
RNA and protein levels as a control for the JQ1 treatment in
CD4+ T cells (Supplementary Fig. 2a). We compared the HIV-1
insertion proﬁles with or without JQ1 by inverse PCR (see
“Methods”). We mapped a total of 38,964 HIV-1 insertion sites
and did not observe, at the chromosome scale, that JQ1 affects
the insertion biases (Supplementary Fig. 2b, left panel).
Similarly, spatial localization of the provirus and two repre-
sentative RIGs remained unchanged upon treatment (Supple-
mentary Fig. 2c, d).
Transcriptional proﬁling of activated CD4+ T cells conﬁrmed
that protein-coding genes proximal to SEs are signiﬁcantly more
upregulated or downregulated upon JQ1 treatment than coding
genes without SEs (Supplementary Fig. 2e, f). This effect is more
pronounced among RIGs than among non-targeted genes
(Supplementary Fig. 2f). Of note, HIV-1 maintains its preferences
for highly transcribed genes in both control and JQ1-treated cells
(compare Fig. 2a and Supplementary Fig. 2g).
In summary, our gene expression analysis suggests that genes
recurrently targeted by HIV-1 are adjacent to SE elements,
irrespective of their transcriptional levels, but disruption of SEs
does not impact HIV-1 integration patterns.
HIV-1 insertion hotspots are clustered in the nuclear space.
Our previously published results showed that the majority of
tested RIGs are distributed in the outer zones of the T cell
nucleus18, so we hypothesized that the enrichment of HIV-1
insertion sites near SEs may be due to their particular organiza-
tion in the nuclear space. We thus performed Hi-C to get some
insight into the conformation of the T cell genome.
In order to minimize issues caused by the heterogeneity of the
biological material, we used the widely available Jurkat lymphoid
T cellular model. To ensure that the behavior of HIV-1 is similar
in both models, we compared a published collection of 58,240
insertion sites in Jurkat cells28 to the 28,419 insertion sites in
primary CD4+ T cells from the current study (obtained by
linear ampliﬁcation-mediated and inverse PCR) and previous
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Fig. 2 RIGs are proximal to super-enhancers regardless of their expression. a Regularized log-transformed read counts on protein-coding genes averaged
over three replicates in activated CD4+ T cells shown as violin plot for genes without HIV-1 integrations and genes with HIV-1 integrations. b Box plot for
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studies38,39,51–54. The insertion rates per chromosome are similar
between cells (Fig. 3a); both show the characteristic approxi-
mately threefold increase on chromosomes 17 and 19. The
apparent difference on chromosome 17 is possibly due to the use
of different mapping technologies. For comparison, our previous
measure of the insertion rates on chromosome 17 of Jurkat cells29
(using the same inverse PCR technology) is very close to the
current measure in primary CD4+ T cells. The insertion cloud
representation shows that the proﬁles are similar on chromosome
17, with the exception of a hotspot visible only in primary CD4+
T cells at position ~57Mb (Fig. 3b). We also found that the HIV-
1 target genes are similar in Jurkat cells and in other CD4+
datasets (Supplementary Fig. 3). In summary, apart from minor
differences, HIV-1 insertion biases are comparable in primary
CD4+ T and in Jurkat cells.
Hi-C on uninfected Jurkat cells yielded ~1.5 billion informative
contacts. Topologically associating domains (TADs) and loop
domains are clearly visible on the raw Hi-C map in 5 kb bins (Fig.
3c), showing that the experiment captures the basic structural
features of the Jurkat genome. We also veriﬁed that the A and B
compartments are well deﬁned and that they correspond to the
regions of high and low gene expression, respectively (data not
shown). To our knowledge, this dataset constitutes the highest-
resolution Hi-C experiment presently available in Jurkat cells.
If the insertion pattern of HIV-1 reﬂects a particular
organization of the genome, one predicts that the insertion
hotspots occupy the same nuclear space and thus cluster together
in three dimension (3D). We tested this hypothesis by measuring
the amount of inter-chromosomal Hi-C contact densities among
different classes of HIV-1 insertion sites (Fig. 3d). The loci most
targeted by HIV-1 engage in stronger contact with each other
than non-targeted loci. Also, the differences in contact strength
are more pronounced when loci correspond to active genes. In
addition, SEs tend to cluster together and with HIV-1 insertion
hotspots in 3D (Fig. 3e, Supplementary Fig. 4), indicating that SEs
locate in the physical proximity of HIV-1 insertion sites. Thus
HIV-1 insertion sites form spatial clusters interacting with SEs in
the nucleus, consistently with the view that the insertion process
depends on the underlying 3D organization of the T cell genome.
SEs and HIV-1 occupy the same 3D sub-compartment. To
better deﬁne the properties of HIV-1 insertion sites, we seg-
mented the Jurkat genome into spatial clusters. For each chro-
mosome, we generated 15 clusters of loci enriched in self
interactions, which we coalesced down to 5 genome-wide clusters
based on their inter-chromosomal contacts (Fig. 4a and see
“Methods”). This approach yielded two A-type sub-compart-
ments called A1 and A2, two B-type sub-compartments called B1
and B2, and one intermediate/mixed compartment called AB
(Fig. 4b, c).
The AB- and B-type sub-compartments correspond to known
types of silent chromatin: AB is richest in the Polycomb mark
H3K27me3, B1 is richest in H3K9me3, and B2 is richest in lamin
(Fig. 4d and Supplementary Fig. 5a). The two A-type sub-
compartments are enriched in euchromatin marks, with higher
coverage in A1 than in A2 (Fig. 4d and Supplementary Fig. 5a).
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Strikingly, the rate of HIV-1 insertion is 2.7 times higher in A1
than in A2 (Fig. 4e). In contrast, the coverage of euchromatin
marks and the transcriptional activity are only slightly higher in
A1 than in A2 (Fig. 4d, f), e.g., 1.04 times higher in H3K27ac
coverage, 1.09 times in H3K36me3 coverage, and 1.12 times in
median gene expression. More importantly, the ~2.5-fold
enrichment of HIV-1 insertion is still present when controlling
for gene expression (Supplementary Fig. 5b), indicating an
intrinsic preference for the A1 sub-compartment. Of note, we
obtained similar results when deﬁning 10 sub-compartments
instead of 5, where HIV-1 insertion rates are enriched in one sub-
compartment covering ~10% of the genome (data not shown).
Hence, our observation is robust with respect to the deﬁnition of
sub-compartments. The 3D organization of the Jurkat T cell
genome thus explains large differences of HIV-1 insertion rates
between genes expressed at similar levels.
If HIV-1 targets SEs because of their location in the nuclear
space, one predicts that the insertion rate of HIV-1 in the SEs of
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A1 should be higher than in the SEs of A2. Figure 4g shows that,
indeed, HIV-1 is ~1.5 times more likely to integrate in the SEs of
A1 than in those of A2. Since the insertion rate in SEs depends
primarily on their location, we conclude that the enrichment in
SEs at genome-wide scale is due to their position in the 3D space
of the nucleus, rather than to their activity or their chromatin
features.
To quantify this statement and to clarify how different
determinants contribute to HIV-1 insertion, we used a
modeling approach based on logistic regression. We predicted
either typical HIV-1 target genes (top 33% gene-wide insertion
rate) or HIV-1 hotspots (top 2.5% bin-wise insertion rate, see
“Methods”). Typical HIV-1 targets are almost entirely
determined by gene expression (Fig. 4h), consistently with
previous reports that HIV-1 integrates primarily in active
genes2,3,20. On the other hand, HIV-1 hotspots are multi-
factorial and sub-compartments appear as the major determi-
nants (Fig. 4h). These results establish that typical HIV-1
targets and hotspots, such as RIGs, are driven by different
classes of mechanisms. Finally, they show that the 3D
organization is a major contributor of HIV-1 hotspots.
Genes proximal to SEs reposition upon T cell activation. Our
results so far suggest that HIV-1 insertion hotspots cluster near
SEs because of their location in the structured genome of T cells,
but they do not address the contribution of SEs to this structure.
We thus investigated the role of SEs in the spatial distribution
of genes in T cells. RIGs belong to a subset of T cell genes that
show the strongest response to T cell activation (Supplementary
Fig. 6a), so we reasoned that their spatial positioning might
change with the activation status of the cell. We therefore
employed 3D immuno-DNA ﬂuorescence in situ hybridization
(FISH) to visualize gene positioning in resting and activated CD4
+ T cells. The cumulative frequency plots revealed that nine RIGs,
seven of which have SEs FOXP1, STAT5B, NFATC3 (Fig. 5a),
KDM2A, PACS1 (Fig. 5b), and GRB2, RNF157 (Fig. 5c), change
spatial positioning and relocalize further toward the outer shells
of the T cell nucleus upon activation. Three RIGs, NPLOC4,
RPTOR, and BACH2, were already peripheral before activation
and remained so afterwards (Supplementary Fig. 6c). We
recapitulated the overall distribution of 9 RIGs that displayed
repositioning in activated (n= 1690 alleles) vs resting CD4+
T cells (n= 1700 alleles, Fig. 5d). As expected, the frequency
distribution of alleles in three zones of equal surface areas18
showed a prominent shift toward the outer shells of the nucleus
in activated T cells, corresponding to the area located <1 micron
under the nuclear envelope. Of note, a pan nuclear distribution of
KDM2A and PACS1 in activated CD4+ T cells was also
observed26.
We then asked whether the observed gene redistribution is an
exclusive feature of genes proximal to SEs or a general feature of
all expressed genes, independent of HIV-1 targeting. We
therefore evaluated the spatial distribution of two groups of
control genes: expressed genes with SEs and expressed genes
without SEs. The MYC gene, a gene harboring ﬁve well-described
SEs, changed its radial position toward the outer shells of the
nucleus upon T cell activation (Supplementary Fig. 6d). The same
trend was observed for two other regions proximal to SEs that are
not targeted by the virus: one on chromosome 1 covering the gene
LMNA and the other on chromosome 11 encompassing
SLC43A1, UBE2L6, and TIMM10. Both regions showed statisti-
cally signiﬁcant repositioning toward the more exterior shells of
the nucleus with T cell activation.
In contrast, when we assessed the spatial distribution of three
highly expressed genes without SEs, TAP1, CCNC, and MCM4,
we did not observe any statistically signiﬁcant allele redistribution
upon T cell activation (Supplementary Fig. 6e).
Next, we wanted to understand whether disruption of SEs
impacts the nuclear position of genes proximal to these elements
during T cell activation. To do so, we pretreated resting T cells
with JQ1 before activating them with CD3/CD28 beads and
observed that the two tested RIGs, STAT5B and GRB2, retained
their position in the center of the nucleus (Supplementary Fig. 6g,
h), supporting the notion that SEs contribute to the positioning of
genes prior and during T cell activation.
As HIV-1 target genes group together on linear chromo-
somes18 and integration hotspots cluster in the nuclear space (Fig.
3e and Supplementary Fig. 4), we assessed their spatial relation-
ships during T cell activation. Two highly targeted regions
(top 10% of RIGs density) on chromosomes 11 and 17 were
visualized by dual-color FISH coupled to high-throughput
imaging (HTI)65,66. We observed that KDM2A and PACS1, two
genes proximal to SEs lying at 1.1 Mb from each other on
chromosome 11 (Fig. 5e), clustered together in the nuclear space,
with a minimized median distance of 0.42 μm in both resting and
activated state (data summarized in Supplementary Fig. 6f).
Similarly, we found that, in the hotspot region mapping to q25.1-
3 on chromosome 17 containing 35 RIGs (Fig. 5f), three RIGs,
GRB2, TNRC6C, and RNF157, cluster together (Fig. 5f, data
summarized in Supplementary Fig. 6f). This clustering is not a
mere consequence of the linear distances between these genes, as
two other genes from the same locus, NPLOC4 and RPTOR,
despite being at a similar linear distance, are not spatially
associated (measured distances given in Supplementary Fig. 6f).
In summary, our results show that seven out of nine RIGs
proximal to SEs change their radial positioning upon T cell
activation, moving to the outer shell of the nucleus. This is a
feature pertinent also to genes proximal to SEs that are not HIV-1
targets, suggesting that SEs contribute to the spatial organization
of the genome and that in dependence of the activation state
could be more exposed to HIV-1 insertions.
Discussion
The integration of the viral DNA into the host cell genome is
responsible for the long-term persistence of HIV-1 in cellular
reservoirs67. The persistence of HIV-1 is inﬂuenced by the
chromosomal context at the sites of integration, with a strong
impact on the outcome of viral infection29. Here we characterized
the genomic features of integration sites identiﬁed from
patients38,39,51–54 and from in vitro infections of activated CD4+
T cells (ref. 50 and this study). By analyzing these large datasets,
we conﬁrmed that HIV-1 recurrently integrates into a subset of
transcriptionally active cellular genes. We show that HIV-1
recurrently integrates into a group of genes proximal to SE
genomic elements in activated CD4+ T cells and in patients (Fig.
1c). Yet, neither the activity of SEs nor their effect on gene
expression alone explain the integration biases (Supplementary
Fig. 2b). Instead, we found that the correlation can be attributed
to the enrichment of SEs in the A2 and especially in the A1 sub-
compartments, where HIV-1 integrates at higher frequency than
in the rest of the genome (Fig. 4e).
The contribution of gene expression levels to the insertion rate
of HIV-1 is intricate. On one hand, HIV-1 shows a clear bias
toward expressed genes, even upon JQ1 treatment where it still
integrates preferentially into genes that are most active after JQ1
treatment. However, HIV-1 recurrently integrates into genes
proximal to SEs (Fig. 2d), among which there are both upregu-
lated and downregulated genes (Supplementary Fig. 2f). One
potential explanation is that the HIV-1 IN has a strong afﬁnity for
some protein present in transcribed regions (e.g., LEDGF). The
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complete absence of such proteins in non-transcribed regions
would have more inﬂuence on the signal than its quantitative
variations in transcribed regions. In any event, gene expression
and chromatin are not the sole contributors to HIV-1 insertion
patterns. The A1 sub-compartment is targeted more frequently
than the rest of the genome (Fig. 4e), even when controlling for
chromatin and gene expression (Supplementary Fig. 5b). This
indicates that the 3D genome organization of activated T lym-
phocytes is an important determinant of the HIV-1 insertion
process. SEs most likely contribute to this organization42 because
their dismantling prior to T cell activation prevents repositioning
of genes with SEs toward the outer shells of the nucleus (Sup-
plementary Fig. 6g, h).
Predictive modeling helps clarify this conclusion. An important
insight is that HIV-1 insertion hotspots do not obey the same
rules as typical target genes (Fig. 4h). There are thus two pro-
cesses at work: one that attracts viruses to active genes, and
another one, more complex, that provokes recurrent integrations
within the same genes (i.e., the RIGs). 3D compartmentalization
plays a role only in the second process, explaining why studies
with different deﬁnitions of HIV-1 targets may come to different
conclusions.
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Fig. 5 Genes proximal to super-enhancers change their nuclear positioning upon T cell activation. Three-dimensional immuno-DNA FISH of nine RIGs in
resting and activated (anti-CD3/anti-CD28 beads, IL-2 for 48 h) CD4+ T cells (green: BAC/gene probe, red: lamin B1, blue: DNA staining with Hoechst
33342, scale bar represents 2 μm). Cumulative frequency plots show combined data from both experiments (n= 100, black: resting cells, red: activated
cells). The p values of the Kolmogorov–Smirnov tests are indicated. Box plots represent minimized distances (5th−95th percentile) for the analyzed gene
combinations in resting (white) and activated (gray) CD4+ T cells, obtained by high-throughput imaging and subsequent computational measurements. In
the box plots, the center line represents the median, the bounds of the box span from 25% to 75% percentile, and the whiskers visualize 5% and 95% of
the data points. Representative images for a FOXP1, STAT5B, NFATC3, and MKL2; b KDM2A and PACS1; and c GRB2, RNF157, and TNRC6C. d Allele fraction
density plot for all resting and activated alleles that displayed peripheral repositioning. The y-axis shows the allele fraction density for genes FOXP1, STAT5B,
NFATC3, MKL2, KDM2A, PACS, GRB2, RNF157, and TNRC6C. The x-axis represents ratios of distance from nuclear envelope (lamin B1 staining) and radius
(signal to radius ratio) for alleles in resting cells (n= 1700) and activated cells (n= 1690 alleles). Binning into three equal concentric zones of the nucleus
is performed as in ref. 18. e Schematic representation of chromosomal region 11q13.2 within 10Mb: RIGs (bold red) and single HIV-1 integration sites (plain
gray) and HTI of KDM2A and PACS1. f Schematic representation of chromosomal region 17q25.1-3 within 20Mb: RIGs (bold red) and single HIV-1
integration sites (plain gray) and HTI of GRB2, RNF157, and TNRC6C
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Although we show that SEs do not affect HIV-1 integration
patterns in activated T cells, we ﬁnd that, during T cell activation,
genes with SEs move toward the outer shells of the nucleus (Fig.
5a–c). In line with the previously shown association of nuclear
pore proteins with HIV-118,19, and their proximity to SEs and
enrichment in the A1 sub-compartment deﬁned here (ref. 41 and
data not shown), it is tempting to speculate that the A1 sub-
compartment corresponds to genomic loci associated with the
nuclear pore. None of the chromatin features mapped in Jurkat
cells is known to discriminate active genes at the nuclear pore
from other active genes, and the chromatin of A1 is otherwise
similar to that of A2 (Supplementary Fig. 5a). Interestingly, the
density of SEs is similar between A1 and A2 (Supplementary Fig.
5a), so it is unlikely that the A1 sub-compartment simply emerges
from the clustering of SEs. More plausibly, SEs are one of many
contributors to the segregation of the genome in spatial clusters.
More generally, the existence of two separate clusters of active
genes in the 3D space of the nucleus is itself an intriguing
observation that will require more work to be fully understood.
While the spatial positioning of the A1 and A2 sub-
compartments in T cells still needs to be mapped, a recent
study proposed an alternative concept to the one where nuclear
periphery represents solely transcriptionally repressive
environment68,69. Instead, and consistently with our ﬁndings,
they predict distinctive localization of active A1 and A2 Hi-C sub-
compartments. Transcriptionally active regions are divided into
two groups: a transcriptional “hot zone” close to nuclear speckles
corresponds to the A1 sub-compartment and another one far
from speckles corresponds to A268. Interestingly, transcriptional
hot zones conﬁned within the A1 sub-compartment are enriched
in SEs and highly expressed genes, traits we observed to be
strongly associated with HIV-1 insertional hotspots.
It is well established that the main components that mediate
HIV-1 integration into actively transcribing units are the viral
proteins IN and CA3,17. Their cellular partners LEDGF/p75 and
CPSF6 could chaperone the virus into clusters of SE domains in
the A1 compartment. LEDGF/p75 interacts with a large number
of splicing factors and directs HIV-1 integration to highly spliced
transcription units22, making this a plausible link to the A1
compartment.
Likewise, CPSF6 as part of the mRNA polyadenylation
machinery, could guide HIV-1 integrations toward the nuclear
compartment with high transcription and mRNA processing
rates (such as A168). Alternatively, the CA–CPSF6 axis could
regulate HIV-1 targeting independently of the polyadenylation
role of CPSF624,26,70.
Among the factors that are binding putative SEs and could play
a role in integration site selection, p300 and BRD4 seem to be the
most promising candidates. p300, a histone acetyltransferase used
to identify typical71,72 and SEs32,73,74, is an interaction partner of
the HIV-1 IN. p300 promotes the DNA-binding activity of IN75
and could serve to direct viral integration toward genes with SEs
in the A1 compartment, though a role for p300 in HIV-1 inte-
gration targeting has yet to be established.
BRD4, on the other hand, does not bind HIV-1 IN76,77 but has
a well-established role in HIV-1 latency78,79. The mechanism of
action has recently been ascribed to the short isoform of BRD4,
which recruits a repressive SWI/SNF complex to the viral long
terminal repeat (LTR)80. Loss of the short isoform, occurring
rapidly upon JQ1 treatment, leaves the long isoform engaged in
the transcriptional activation of the viral genome80. The same
mechanism could account for the activation of cellular genes
upon JQ1 treatment31. In fact, our RNA-Seq data show that genes
proximal to SEs are both upregulated and downregulated upon
JQ1 (Supplementary Fig. 2e). Furthermore, genes targeted by
HIV-1 are more responsive to JQ1 than non-HIV-1 targets
(Supplementary Fig. 2g). This implies that HIV-1 preferentially
targets genes that have a rapid and tightly regulated transcrip-
tional response. Given the opposing role of BRD4 on viral LTR
and cellular genes, insertion into genes proximal to SEs might
represent a source of transcriptional ﬂuctuations81,82 and play an
important role in either establishment or reversal of latency.
Based on our ﬁndings that the majority of tested RIGs and
genes with SEs reposition from the nuclear interior to the per-
iphery during T cell activation, it could be envisaged that RIGs
differ between resting and activated CD4+ T cells. Meta-analysis
of the only available integration sites dataset50 from these two cell
activation states showed, however, no signiﬁcant difference.
Additional work will thus be required to assess comprehensively
the RIGs that are used by HIV-1 in resting T cells.
Overall, we show that HIV-1 insertion sites form spatial clus-
ters interacting with SEs of A1 compartment, highlighting the
importance of the underlying 3D genome organization for HIV-1
integration. While additional studies will be needed to decipher
the mechanism of such site selection, our results identify hotspots
of integration that could improve characterization and enable
targeting of latent HIV-1 reservoirs.
Methods
Primary cell isolation, culture, treatments, and infection. For CD4+ T cells
isolation, whole blood was mixed with RosetteSep Human CD4+ T cell enrichment
cocktail beads according to the manufacturer’s instructions and CD4+ T cells were
separated using Histopaque Ficoll gradient by centrifugation. Cells were cultured in
complete T cell medium (RPMI-1640+10% fetal bovine serum (FBS)+ primocin),
left in resting state or activated with Dynabeads Human T-Activator CD3/CD28
and plated in complete medium supplemented with 5 ng/ml IL-2 for 20–72 h
at 37 °C.
Cells were treated when indicated with 500 nM JQ1(+) or dimethyl sulfoxide
(DMSO) for 6 h at 37 °C.
In all, 1 × 106 activated CD4+ T cells were infected with 0.5–1 µg of p24 of virus
by spinoculation for 90 min at 2300 rpm at room temperature (RT) in the presence
of polybrene at 37 °C. Virus stocks were produced from the viral clone HIV-1NL4_3
and a mutant that harbors a frameshift (FS) mutation in the env gene (pNL4_3-
envFS) and was pseudotyped with vesicular stomatitis virus glycoprotein, resulting
in a FS virus that performs a single-round infection (HIV-1NL4_3 FS). Cells were
then incubated for 72 h at 37 °C. When indicated, 14 h after infection with HIV-
1NL4_3, cells were treated with the fusion inhibitor T20 to prevent multiple
infection and integration. All viral stocks were generated by transfecting viral DNA
in HEK 293T cells and collecting supernatants after 48–72 h following sucrose
gradient puriﬁcation of virus articles. Viral production was quantiﬁed in the
supernatants for HIV-1 p24 antigen content using the Innotest HIV Antigen mAB
Kit (INNOGENETICS N.V. Gent, Belgium). The human Jurkat T cell line
(obtained from the cell collection of the Center for Genomic Regulation, Barcelona)
was grown at 37 °C under a 95% air and 5% CO2 atmosphere, in RPMI 1640
medium (Gibco) supplemented with 10% FBS (Gibco), 1% penicillin–streptomycin
(Gibco), and 1% GlutaMAX (100×) (Gibco). Jurkat cells were passaged every 2 days
with a 1:5 dilution. Cells were tested for mycoplasma regularly.
Fluorescence in situ hybridization. Approximately 3 × 105 CD4+ T cells were
plated on the PEI-coated coverslips placed into a 24-well plate for 1 h at 37 °C.
Cells were treated with 0.3× phosphate-buffered saline (PBS) to induce a hypotonic
shock and ﬁxed in 4% paraformaldehyde (PFA)/PBS for 10 min Coverslips were
extensively washed with PBS and cells were permeabilized in 0.5% triton X-100/
PBS for 10 min. After three additional washings with PBS-T (0.1% tween-20),
coverslips were blocked with 4% bovine serum albumin (BSA)/PBS for 45 min at
RT and primary antibody anti-lamin B1 ab16048, from Abcam (1:500 in 1% BSA/
PBS), was incubated overnight at 4 °C. Following three washings with PBS-T,
ﬂuorophore-coupled secondary antibody (anti-rabbit, coupled to Alexa 488
#11034, Alexa 568 #A11011, or Alexa 647 #A27040 from Invitrogen, diluted 1:1000
in 1% BSA/PBS) were incubated for 1 h at RT, extensively washed, and post ﬁxed
with ethylene glycol bis(succinimidyl succinate) (EGS) in PBS. Coverslips were
washed three times with PBS-T and incubated in 0.5% triton X-100/0.5% saponin/
PBS for 10 min. After three washings with PBS-T, coverslips were treated with
0.1 M HCl for 10 min, washed three times with PBS-T, and additionally permea-
bilized step in 0.5% triton X-100/0.5% saponin/PBS for 10 min. After extensive
PBS-T washings, coverslips were equilibrated for 5 min in 2× saline sodium citrate
(SSC) and then put in hybridization solution overnight at 4 °C. For the HIV-1
FISH, RNA digestion was additionally performed beforehand using RNAse A (100
µg/ml).
For FISH without immunoﬂuorescence (IF) for HTI, 1–2 × 106 CD4+ T cells in
500 µl of medium were adhered to coverslips by centrifugation at 350 × g for 10
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min at RT. The coverslips were washed in PBS and the cells were ﬁxed in 4% PFA/
PBS for 10 min followed by extensive PBS washing. Permeabilization was
performed by incubation in 0.5% triton X-100/0.5% saponin/PBS for 20 min. After
three washings with PBS, cells were treated with 0.1 M HCl for 15 min. Coverslips
were washed twice for 10 min with 2× SSC and put in hybridization solution
overnight at 4 °C.
For DNA probe labeling, bacterial artiﬁcial chromosome (BAC) or P1 artiﬁcial
chromosome (PAC) DNA was extracted using a Nucleobond Xtra Maxiprep or
ampliﬁed by the Illustra GenomiPhi V2 DNA Ampliﬁcation Kit according to the
manufacturer’s instructions. HIV-1 plasmid HXB2 was puriﬁed using the Qiagen
Plasmid Extraction Kit. FISH probes were generated in a Nick translation reaction
using three different protocols. All BACs/PACs are listed in Supplementary
Table 5.
BACs were labeled with digoxigenin (DIG)-coupled dUTPs. Three micrograms
of BAC DNA were diluted in H2O in a ﬁnal volume of 16 μl. Four microliters of
DIG-Nick translation mix (Roche) were added and the labeling reaction was
carried out at 15 °C for up to 15 h. The labeling reaction was performed by using a
ﬂuorophore-coupled dUTPs in the same concentration as biotin-16-dUTP in ref. 2.
For HIV-1 labeling, a biotin-dUTP nucleotide mix containing 0.25 mM dATP,
0.25 mM dCTP, 0.25 mM dGTP, 0.17 mM dTTP, and 0.08 mM biotin-16-dUTP in
H2O was prepared. Three micrograms of pHXB2 were diluted with H2O in a ﬁnal
volume of 12 μl, and 4 μl of each nucleotide mix and Nick translation mix (Roche)
were added. Labeling was performed at 15 °C for 3–6 h.
For dual-color FISH or improvement of signal-to-noise ratio in single-color
FISH, probes were labeled using the ﬂuorophore-coupled nucleotides
SpectrumGreen dUTP (Abbott), SpectrumOrange dUTP (Abbott), and Red 650
dUTP (Enzo).
In all, 1–3 μg of BAC DNA were diluted in a ﬁnal volume of 22.5 μl H2O. Also,
2.5 μl of 0.2 mM ﬂuorophore-coupled dUTP, 5 μl of 0.1 mM dTTP, 10 μl of dNTP
mix containing 0.1 mM of each dATP, dCTP, and dGTP, and 5 μl of 5× Nick
translation buffer (Abbott) were added and reagents were mixed well by vortexing.
The reaction was started by addition of 5 μl Nick translation enzymes (Abbott) and
incubated at 15 °C for 13–14 h. The probes were checked for their size on a 1%
agarose gel, and 200–500 bp probes were puriﬁed using Illustra Microspin G-25
columns according to the manufacturer’s instructions. Probes were precipitated in
ethanol, dissolved in formamide and 4× SSC/20% dextran sulfate (1:1), and stored
at −20 °C prior to use.
For probe hybridization, 1–6 µl of probe was loaded on glass coverslips and heat
denatured in metal chamber at 80 °C for 8 min in a water bath. Hybridization was
carried out for 48 h at 37 °C. Four washings in 2× SSC (10 min each) at 37 °C were
followed with 2 washings in 0.5× SSC at 56 °C.
FISH development for DIG-labeled BACs was performed by using ﬂuorescein
isothiocyanate (FITC)-labeled anti-DIG antibody (Roche), whereas biotin-labeled
HIV-1 probes were detected by TSA Plus system from Perkin Elmer, that allows
signiﬁcant ampliﬁcation of the signal, by using an anti-biotin antibody (SA-HRP)
and a secondary antibody with a ﬂuorescent dye (usually FITC for HIV).
For the directly labeled probes after initial washings, nuclei were stained with
Hoechst 33342 (1:5000 in PBS), washed in PBS, and then mounted using mowiol.
Microscopy and image analysis. For the classical confocal microscopy and
manual image analysis, 3D stacks were acquired with a Leica TCS SP8 confocal
microscope using a ×63 oil immersion objective. Distance measurements were
performed using Volocity (Perkin Elmer). The smallest distance between the FISH
signal and the nuclear lamina, stained by IF for lamin B1, was determined, and
measurements were normalized to the nuclear radius (deﬁned as half of the
maximum diameter of the lamin B1 ring). Signal-to-radius ratios were either
binned into three classes of equal surface (zones 1–3)18 or plotted on a cumulative
frequency plot. Kolmogorov–Smirnov (KS) tests were performed to compare the
distributions of positioning of a gene between two conditions (resting vs activated
or DMSO vs JQ1).
For HTI and image analysis of dual-color FISH, images were acquired with a
spinning disk Opera Phenix High Content Screening System (PerkinElmer),
equipped with four laser lines (405 nm, 488 nm, 568 nm, 640 nm). Images of FISH
experiments to calculate 3D distances were acquired in confocal mode using a ×40
water objective lens (NA 1.1) and two 16 bit CMOS cameras (2160 by 2160 pixels),
with camera pixel binning of 2 (corresponding to 299 nm pixel size). For each
sample, 11 z-planes separated by 0.5 µm were obtained for a total number of at
least 36 randomly sampled ﬁelds, which acquired per condition a minimum of
16 × 103 cells. Image analysis was performed using the Harmony high-content
imaging and analysis software (version 4.4, Perkin Elmer), using custom-made
image analysis building blocks. Nuclei were segmented based on the Hoechst nuclei
staining signal of maximum projected images using the algorithm B and cells in the
periphery of the image were excluded from further analysis. FISH probe detection
was performed by using the spot detection algorithm C and custom-made scripts
were used to calculate the Euclidean distances between all the different colored
probes per cell. Single cell-level data were then exported and custom-made R
scripts were used to select the minimum distance between the different FISH
probes per allele basis. To exclude spurious spot detection events from the analysis,
only the distances of cells with two FISH probes detected per channel were
calculated and plotted (Graph Pad, Prism).
Quantitative real-time PCR (qPCR). Up to 5 × 106 CD4+ T cells were used for
RNA extraction with the InviTrap Spin Kit (Stratec Biomedical) according to the
manufacturer’s instructions and up to 500 ng of RNA was retro-transcribed using
Moloney MLV reverse transcriptase from Invitrogen according to the manu-
facturer’s instructions. Gene expression analysis were performed in duplicates
using IQ supermix from Biorad in CFX96/C1000 Touch Real-Time PCR system, as
described in Lusic et al., 2013. Statistical analysis of qPCR data was performed
using Graphpad. Taqman assays used were: for MYC Taqman Hs00153408_m1
FAM/MGB and for GAPDH 4310884E VIC/TAMRA.
Western blotting. In all, 5 × 106 cells were harvested and homogenized in lysis
buffer (20 mM Tris-HCl, pH 7.4, 1 mM EDTA, 150 mM NaCl, 0.5% Nonidet P-40,
0.1% sodium dodecyl sulfate (SDS), 0.5% sodium deoxycholate) supplemented with
protease inhibitors (Roche) for 10 min at 4 °C and sonicated (Bioruptor) for 5 min.
Equal amounts of total cellular proteins (20 μg), as measured with Bradford reagent
(Biorad), were resolved by 10% SDS-polyacrylamide gel electrophoresis, transferred
onto nitrocellulose membrane (GE Healthcare), and then probed with primary
antibody, followed by secondary antibody conjugated with horseradish peroxidase.
The immuno-complexes were visualized with enhanced chemiluminescence kits
(GE Healthcare). Antibodies used were: for MYC 9E10, # sc-40 (1:500) from Santa
Cruz and for actin Anti-β-Actin AC-74, # A5316 (1:5000) from Sigma Aldrich.
Flow cytometric analysis. T cell activation with CD3/CD28 activating beads was
controlled with CD25 and CD69 activation markers. Approximately 150,000 were
ﬁxed in 3% PFA for 10 min at RT. Cells were washed in 1% FBS/PBS and stained
with the corresponding antibody for 45 min on ice, (1:50 dilution was used for
CD25 FITC, #555431 from BD and CD69 BV510 #310929 from Biolegend). Cells
were extensively washed and proﬁled using BD FACSVerse™ instrument. Gates for
activation marker-positive cells were set by utilizing unstained controls. FlowJo
software was used for the data analysis. Gating strategy is described in Supple-
mentary Fig. 7.
Chromatin immunoprecipitation. In all, 20 × 106 CD4+ T cells were washed 1
time in PBS prior to crosslinking with 1% formaldehyde for 10 min at RT, followed
by termination of the reaction with 125 mM glycine on ice. Cell pellet was washed 2
times with PBS at 4 °C and was lysed in 0.5% NP-40 buffer (10 mM Tris-Cl pH 7.4,
10 mM NaCl, 3 mM MgCl2, 1 mM PMSF, and Protease Inhibitors). For histone
ChIPs, obtained nuclei were washed once in the same buffer without NP-40. Nuclei
were resuspended in 0.5% NP-40 buffer supplemented with 0.15% SDS and 1.5 mM
CaCl2. Nuclei were incubated at 37 °C for 10 min prior to addition of Micrococcal
Nuclease (16 units of the enzyme), and the reaction was stopped after 7 min with 3
mM EGTA. DNA was additionally sheared by sonication (Covaris or Bioruptor,
Diagenode) to an average size of DNA fragments <500 bps. Extracts were then
diluted up to 0.01% SDS, 1% Triton-X, 20 mM Tris pH 8, 150 mM NaCl, and 2
mM EDTA. Extracts were precleared by 1-h incubation with protein A/G Magna
ChIP beads at 4 °C and diluted with 5× IP buffer to a ﬁnal concentration of 140
mM NaCl and 1% NP-40. Lysate corresponding to 3−4 × 106 million of cells was
then incubated with 2–4 µg of the indicated antibody overnight at 4 °C, followed by
a 2.5-h incubation with Magna ChIP Protein A/G Magnetic Beads (Millipore).
Beads were then washed thoroughly with RIPA150, with LiCl-containing buffer
and with TE buffer, RNAse treated for 1 h at 37 °C, and Proteinase K treated for 2 h
at 56 °C. Decrosslinking of protein–DNA complexes was performed by an over-
night incubation at 65 °C. Additional 1 h of Proteinase K digestion was performed
at 56 °C and DNA was then extracted using Agencourt AMPure XP beads
(Beckman Coulter) and quantiﬁed by real-time PCR. The following antibodies were
used for ChIP: H3K27ac (ab4729), H3K4me3 (ab8580) H3K36me3 (ab9050), IgG
Rabbit (ab46540).
ChIP-Seq and RNA-Seq. ChIP-Seq: Approximately 10 ng of the corresponding
inputs and ChIP-ed DNA from primary CD4+ T cells: H3K27ac, H3K4me3,
H3K36me3, H4K20me1, and H3K9me2, IPs were prepared for sequencing using
the NEBNext® Ultra™ II DNA Library Prep Kit for Illumina®.
RNA-Seq: 5 × 106 DMSO and 500 nM JQ1-treated CD4+ T cells from three
independent donors were used for RNA extraction with the InviTrap Spin Kit
(Stratec Biomedical) according to the manufacturer’s instructions and libraries for
sequencing were prepared by using the rRNA Depletion Kit NEBNext® and
NEBNext® Ultra™ RNA Library Prep Kit for Illumina®. Sequencing was performed
with 2 × 75 bp read length on the NextSeq platform.
In situ Hi-C protocol. Hi-C was performed based on the protocol published by Rao
et al.83 with modiﬁcations. Brieﬂy, one million cells were crosslinked with 1%
formaldehyde for 10 min at RT with gentle rotation. Nuclei were permeabilized by
0.25 ml freshly prepared ice-cold Hi-C lysis buffer [10 mM Tris-HCl pH 8.0,
10 mM NaCl, 0.2% Igepal CA630 (Sigma, I8896–50ML), and 1× Roche complete
protease inhibitors (Roche, 11836153001)]. DNA was digested with 100 units of
MboI (NEB, R0147M) at 37 °C overnight, and the ends of digested fragments were
ﬁlled in by using 0.4 mM biotinylated deoxyadenosine triphosphate (biotin-14-
dATP; Life Technologies, #65001) and ligated in 1 ml by incubating at 24 °C
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overnight with gentle rotation. After reversal of the crosslinks, ligated DNA was
puriﬁed and sheared to a length of 400 bp. Ligation junctions were pulled down
with 75 μl of 10 mg/ml streptavidin C1 beads. Ten microliters of DNA-on-beads
were ampliﬁed in 50 μl standard Herculase II Fusion DNA Polymerase reaction
mix (Agilent Technologies, #600675) with 1 μM NEBNext Universal primer and
index primer (NEB, E6040S). The cycling conditions were as follows: 98 °C for 2
min; 98 °C for 20 s, 65 °C for 30 s, and 72 °C for 45 s (8 cycles); and 72 °C for 3 min.
PCR products were puriﬁed with 1.0× Agencourt AMPure XP beads (BECKMAN
COULTER, A63880). Libraries ran as a smear on 1.5% agarose gel and estimate of
the size of a smear was around 300 bp. The quality of the libraries was assessed by
digesting with ClaI (NEB, R0197S) and checking that the smear shifts downwards.
Reporting summary. Further information on research design is available in the
Nature Research Reporting Summary linked to this article.
Data availability
All relevant data supporting the key ﬁndings of this study are available within the article
and its Supplementary Information ﬁles or from the corresponding authors on
reasonable request. The RNA- Seq of resting and activated CD4+ T cells is available from
Gene Expression Omnibus (GEO; Lucic et al. GSE122735), ChIP-Seq on primary CD4+
T cells (Lucic et al. GSE GSE122826), in situ Hi-C data (Chen et al. GSE122958).
Integration site raw data on in vitro infected CD4+ T cells are available from GSE134382.
A reporting summary for this Article is available as a Supplementary Information ﬁle.
Code availability
Code for processing raw sequences to get integration sites is available here: https://github.
com/gui11aume/genome_structure_and_HIV_integration/blob/master/maja/
Brady_Integration_Sites.md. Integration sites used in this analysis are available as an R
object containing a list of GRanges objects, one list element for each dataset used; https://
github.com/gui11aume/genome_structure_and_HIV_integration/blob/master/maja/is.
Robj. The matrix that contains the number of lists each gene is found in all 100
randomizations can be found here (in RDS format): https://github.com/gui11aume/
genome_structure_and_HIV_integration/raw/master/maja/Replicates.RDS. Genuine Hi-
C contacts were validated with the Hi.C pipeline (https://github.com/ezorita/hi.c).
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